SCHEMBL29025261

SCHEMBL29025261

COc1nc2c(cc1Nc1ncc(C)c(NCC(C)(C)C(N)=O)n1)CN(C)CC2

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30462516 1.00 MAP4K1 (0.47) MAP4K1
SCHEMBL30462517 0.93 MAP4K1 (0.49) MAP4K1
SCHEMBL29025233 0.93 MAP4K1 (0.49) MAP4K1
SCHEMBL29025264 0.79 MAP4K1 (0.46) MAP4K1
SCHEMBL29087135 0.78 MAP4K1 (0.49) MAP4K1
SCHEMBL30643737 0.78 MAP4K1 (0.49) MAP4K1
SCHEMBL24394165 0.76 TTK (0.56) —
SCHEMBL29539200 0.75 TTK (0.64) —
SCHEMBL24394188 0.75 TTK (0.64) —
SCHEMBL30570439 0.73 MAP3K14 (0.44) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116348117-A HPK1 kinase inhibitor compounds 杭州阿诺生物医药科技有限公司 2023-06-27 — — CN disclosed
Send feedback